4//SEC Filing
HEMOSENSE INC 4
Accession 0001181431-05-039069
CIK 0001127393operating
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:30 PM ET
Size
15.5 KB
Accession
0001181431-05-039069
Insider Transaction Report
Form 4
VANGUARD V L P
Other
Transactions
- Conversion
Series A-3 Preferred Stock
2005-07-01−500,000→ 0 total→ Common Stock (125,000 underlying) - Conversion
Series C-3 Preferred Stock
2005-07-01−1,664,528→ 0 total→ Common Stock (416,130 underlying) - Conversion
Common Stock
2005-07-01+699,357→ 699,357 total - Conversion
Series B-3 Preferred Stock
2005-07-01−632,911→ 0 total→ Common Stock (158,227 underlying)
Transactions
- Conversion
Common Stock
2005-07-01+699,357→ 699,357 total - Conversion
Series B-3 Preferred Stock
2005-07-01−632,911→ 0 total→ Common Stock (158,227 underlying) - Conversion
Series A-3 Preferred Stock
2005-07-01−500,000→ 0 total→ Common Stock (125,000 underlying) - Conversion
Series C-3 Preferred Stock
2005-07-01−1,664,528→ 0 total→ Common Stock (416,130 underlying)
Footnotes (4)
- [F1]Not applicable.
- [F2]Each share of Series A-3, B-3 and C-3 Preferred Stock converted into Common Stock on a 1-for-4 basis immediately prior to the closing of the issuer's initial public offering.
- [F3]Immediately.
- [F4]The reported securities are owned directly by Vanguard V, L.P., and indirectly by Vanguard V Venture Partners, LLC, as general partner of Vanguard V, L.P. Vanguard V Venture Partners, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
Issuer
HEMOSENSE INC
CIK 0001127393
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001127393
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 6:30 PM ET
- Size
- 15.5 KB